Alere is a global leader in rapid point-of-care diagnostics, offering a diverse range of tests for infectious diseases, cardiac conditions, and toxicology. The company's products and services help healthcare providers make faster, more accurate diagnoses, leading to better patient outcomes.
Founded in 1991 in Maine, USA
Acquired Biosite, a leader in protein-based diagnostic tests, in 2007
Expanded globally through multiple acquisitions and partnerships
Acquired by Abbott Laboratories in 2017
The Alere brand was retired in 2018 and integrated with Abbott's diagnostics business
A global leader in in vitro diagnostics, offering a wide range of tests for clinical chemistry, immunochemistry, molecular diagnostics, and more.
A global leader in medical technology, offering a wide range of products and services for diagnostic imaging, laboratory diagnostics, and more.
A leading medical technology company offering a wide range of products for medication management, infection prevention, diagnostic testing, and more.
Rapid point-of-care tests for infectious diseases such as influenza, strep throat, and COVID-19.
Portable point-of-care analyzers for cardiac and toxicology testing.
Rapid tests for detecting and monitoring various health conditions through urine analysis.
Alere is a global leader in rapid point-of-care diagnostics, offering a diverse range of tests for infectious diseases, cardiac conditions, and toxicology.
Alere offers a wide range of rapid point-of-care diagnostic tests for infectious diseases, cardiac conditions, and toxicology.
Alere was acquired by Abbott Laboratories in 2017 and the brand was retired in 2018. Alere's products and services are now integrated with Abbott's diagnostics business.
Alere's rapid diagnostic tests are highly accurate, with sensitivity and specificity rates ranging from 90% to 99%. However, like all diagnostic tests, there is always a risk of false positives or negatives.
Alere's products can be purchased through healthcare providers, hospitals, and diagnostic laboratories. They are not available for direct purchase by consumers.